AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπ²
Streptokinase in Zambia
1 product registered with ZAMRA β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| STPase Injection Powder for Injection | 113/108 | Cadila Pharmaceuticals Limited | active | 28 May 2029 |
Streptokinase β ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Streptokinase, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Streptokinase registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.